- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hiroshima, Japan
- Kanazawa, Japan
- Nagoya, Japan
- Osaka, Japan
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,662 public trials
323 recruiting studies
Multiple Myeloma trial results
NCT03768960
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Avron Hospitals Pvt. Ltd Ahmedabad, India
- M S Ramaiah Medical College and Hospital Bengaluru, India
- Apollo Hospitals Bhubaneswar, India
- Sparsh Hospitals & Critical Care (Pvt) Ltd Bhubaneswar, India
Completed
Bendamustine and Melphalan in Myeloma
NCT03187223
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Department for Medical Oncology University Hospital/Inselspital Bern, Switzerland
Completed
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
NCT04634435
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Completed
Immune Profiling in Multiple Myeloma
NCT04135079
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Aou Citta' Della Salute E Della Scienza Di Torino Torino, TO, Italy
NCT05393024
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- AOU Ospedali Riuniti Umberto I Ancona, Italy
- Policlinico Sant'Orsola Malpighi, Aou Di Bologna Bologna, Italy
- A.O. Spedali Civili di Brescia Brescia, Italy
- Ospedale "A. Businco" Cagliari, Italy
NCT04191057
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- San Francisco General Hospital San Francisco, California, United States
Completed
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
NCT03773107
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- Levine Cancer Institute Charlotte, North Carolina, United States
NCT03997968
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Stanford Comprehensive Cancer Center Stanford, California, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
NCT04028479
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
- Locations
-
- Teton Cancer Institute Idaho Falls, Idaho, United States
- Oncology and Hematology of South Texas Laredo, Texas, United States